Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Medexus Pharmaceuticals Inc (OP: PDDPF )

3.220 USD UNCHANGED
Last Price Updated: 2:34 PM EDT, Aug 19, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Medexus Pharmaceuticals Inc

< Previous 1 2 3 Next >
Medexus Pharmaceuticals Announces Normal Course Issuer Bid
Medexus Pharmaceuticals Inc. (the “Company”) (TSXV: MDP, OTCQB: PDDPF) announced today it has submitted to the TSX Venture Exchange (the “Exchange”) a notice of its intention to make a normal course... 
From GlobeNewswire News Releases
Medexus Pharmaceuticals Launches New Metoject® Subcutaneous 15mg Dosage for the Treatment of Rheumatoid Arthritis, Psoriasis and Psoriatic Arthritis in Canada
Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF), today announced the launch of a new Metoject® Subcutaneous 15mg dose in Canada. Metoject Subcutaneous is a... 
From GlobeNewswire News Releases
Medexus CEO to Present at Two Upcoming Investor Conferences
Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) announces that Ken d’Entremont, Chief Executive Officer, has been invited to present and meet with investors at two... 
From GlobeNewswire News Releases
Medexus to Present at the 2019 LD Micro Virtual Conference
From ACCESSWIRE
Medexus Granted Authorization by Health Canada to Distribute Treosulfan in Canada
Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today announced that Health Canada has authorized the Company to distribute Treosulfan, a conditioning agent used... 
From GlobeNewswire News Releases
Medexus Enters into Expanded Licensing Agreement for Gliolan® in Canada
Prior Phase III study showed complete resection rates and doubling of 6-month progression-free survival in patients receiving Gliolan 
From GlobeNewswire News Releases
Medexus Pharmaceuticals Announces 512% Increase in Revenue to $14.4 Million for the Third Quarter of Fiscal 2019
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today provided a business update and announced its operating and financial results for the... 
From GlobeNewswire News Releases
Medexus Pharmaceuticals Schedules Third Quarter Fiscal 2019 Conference Call
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today announced that it plans to host a conference call at 4:30 PM Eastern Time on Monday,... 
From GlobeNewswire News Releases
Medexus Lists October 2018 Unsecured Convertible Debentures on the TSX Venture Exchange
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the “Company”) (TSXV: MDP, OTCQB: PDDPF) today announced that the 6.0% unsecured convertible debentures of the Company (the “Debentures”) will... 
From GlobeNewswire News Releases
Medexus Files Business Acquisition Report
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the “Company”) (TSXV: MDP, OTCQB: PDDPF) today announced the filing of the Business Acquisition Report (“BAR”) on SEDAR (www.sedar.com) in... 
From GlobeNewswire News Releases
Medexus Announces New Chief Executive Officer, Chair of the Board of Directors, Other Organizational Updates and Equity Incentive Grants
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the “Company”) (TSXV: PDP, OTCQB: PDDPF) today announced organizational changes designed to better position the Company as it continues to... 
From GlobeNewswire News Releases
Medexus Announces New Chief Executive Officer, Chair of the Board of Directors, Other Organizational Updates and Equity Incentive Grants
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the “Company”) (TSXV: PDP, OTCQB: PDDPF) today announced organizational changes designed to better position the Company as it continues to... 
From GlobeNewswire News Releases
Pediapharm Announces Name Change, Consolidation and Debenture Repayment
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the "Company") (TSXV: PDP, OTCQB: PDDPF) is pleased to announce that at the annual general and special meeting of shareholders held on December... 
From GlobeNewswire News Releases
Pediapharm to Present at the 11th Annual LD Micro Invitational
From ACCESSWIRE
Pediapharm Announces Q2 Results – Record Adjusted EBITDA, Record Revenue and 13th Consecutive Year-Over-Year Quarterly Revenue Growth
Pediapharm Inc. (the “Company” or "Pediapharm") (TSXV: PDP, OTCQB: PDDPF) is pleased to file its second quarter financial results ended September 30, 2018. All dollar amounts are expressed in Canadian... 
From GlobeNewswire News Releases
Early Warning Report
On October 11, 2018, 9346-4626 Québec Inc., operating as Transican ("Transican"), acquired (the "Acquisition") 5,882,352 subscription receipts ("Unit Subscription Receipts") convertible into units... 
From GlobeNewswire News Releases
Pediapharm Announces Closing of Transformative Acquisitions, Diversifying and Expanding the Platform for Future Growth
Pediapharm Inc. ("Pediapharm") (TSXV: PDP, OTCQB: PDDPF) is pleased to announce the closing of its previously announced acquisitions of two speciality pharmaceutical companies, transforming the company... 
From GlobeNewswire News Releases
Pediapharm Announces Closing of Subscription Receipt Offering for Total Gross Proceeds of $62 Million
Pediapharm Inc. ("Pediapharm") (TSXV: PDP, OTCQB: PDDPF) is pleased to announce the closing today of its previously announced private placement offering (the "Offering") of Subscription Receipts (as... 
From GlobeNewswire News Releases
Pediapharm Files Corporate Presentation
Pediapharm Inc. ("Pediapharm") (TSXV:PDP) (OTCQX:PDDPF) announces that, further to its press release issued on September 6, 2018, it has filed a corporate presentation on its website setting out... 
From GlobeNewswire News Releases
Pediapharm Announces Transformative Acquisitions and $60 Million Offering of Subscription Receipts
Pediapharm Inc. ("Pediapharm") (TSXV: PDP, OTCQX: PDDPF) is pleased to announce that it has entered into definitive agreements to acquire two speciality pharmaceutical companies and also intends to... 
From GlobeNewswire News Releases
Pediapharm Announces Q1 Results – Record Revenue and 12th Consecutive Year-Over-Year Quarterly Growth
Pediapharm Inc. (the “Company” or "Pediapharm") (TSX VENTURE: PDP) (OTCQB: PDDPF) is pleased to file its first quarter financial results ended June 30, 2018. All dollar amounts are expressed in... 
From GlobeNewswire News Releases
Pediapharm Announces Annual Audited Financial Results – 61% Annual Revenue Growth and 11th Consecutive Year-over-year Quarterly Growth
Pediapharm Inc. (the “Company” or "Pediapharm") (TSX VENTURE:PDP) (OTCQB:PDDPF) is pleased to announce its annual audited results for the year ended March 31, 2018. All dollar amounts are expressed in... 
From GlobeNewswire News Releases
Pediapharm to Present at the 8th Annual LD Micro Invitational
From ACCESSWIRE
Pediapharm to Present at Bloom Burton & Co. Healthcare Investor Conference
Pediapharm Inc. (the “Company” or "Pediapharm") (TSXV:PDP) (OTCQB:PDDPF) has been invited to present at Bloom Burton & Co. Healthcare Investor Conference being held on May 2-3, 2018 at the Sheraton... 
From GlobeNewswire News Releases
Pediapharm Announces the Commercial Launch of Cuvposa™ in Canada
Pediapharm Inc. (the “Company” or "Pediapharm") (TSX VENTURE:PDP) (OTCQB:PDDPF) is very pleased to announce the Canadian commercial launch of Cuvposa™ (Glycopyrrolate oral solution 1 mg/ 5 mL) which is... 
From GlobeNewswire News Releases
Pediapharm annonce les résultats de son troisième trimestre - un 10e trimestre consécutif de croissance d'un exercice à l'autre
From Marketwired
Pediapharm Announces Q3 Results - 10th Consecutive Year-over-year Quarterly Growth
From Marketwired
Pediapharm annonce la prolongation de débentures et de bons de souscription
From Marketwired
Pediapharm Announces Extension of Debentures and Warrants
From Marketwired
Pediapharm fait son entrée sur le marché OTCQB Venture
From Marketwired
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account